Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited)

v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Private Placement Warrants
Public Warrants
At-The-Market Public Offering
Private Placement
Common Stock
Common Stock
Private Placement Warrants
Common Stock
Public Warrants
Common Stock
At-The-Market Public Offering
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement Warrants
Additional Paid-In Capital
Public Warrants
Additional Paid-In Capital
At-The-Market Public Offering
Additional Paid-In Capital
Private Placement
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Common stock, beginning balance (in shares) at Dec. 31, 2023           698,262,025                      
Beginning balance at Dec. 31, 2023 $ 1,034,362         $ 70         $ 2,282,475         $ (1,247,703) $ (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (94,587)                             (94,587)  
Stock-based compensation 35,328                   35,328            
Issuance of common stock upon exercise of stock options (in shares)           1,016,414                      
Issuance of common stock upon exercise of stock options 943                   943            
Issuance of common stock upon the release of restricted stock units (in shares)           6,034,056                      
Vesting of early exercised stock options and common stock issued in private placement 186                   186            
Other comprehensive income (loss) (1,101)                               (1,101)
Common stock, ending balance (in shares) at Mar. 31, 2024           705,312,495                      
Ending balance at Mar. 31, 2024 975,131         $ 70         2,318,932         (1,342,290) (1,581)
Common stock, beginning balance (in shares) at Dec. 31, 2023           698,262,025                      
Beginning balance at Dec. 31, 2023 1,034,362         $ 70         2,282,475         (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (361,757)                                
Common stock, ending balance (in shares) at Sep. 30, 2024           717,094,083                      
Ending balance at Sep. 30, 2024 781,039         $ 71         2,389,751         (1,609,460) 677
Common stock, beginning balance (in shares) at Mar. 31, 2024           705,312,495                      
Beginning balance at Mar. 31, 2024 975,131         $ 70         2,318,932         (1,342,290) (1,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (123,292)                             (123,292)  
Stock-based compensation 28,441                   28,441            
Issuance of common stock upon exercise of stock options (in shares)           424,313                      
Issuance of common stock upon exercise of stock options 312         $ 1         311            
Issuance of common stock upon the release of restricted stock units (in shares)           3,594,727                      
Issuance of common stock under the Employee Stock Purchase Plan (in shares)           1,227,816                      
Issuance of common stock under the Employee Stock Purchase Plan 4,942                   4,942            
Issuance of common stock in acquisition (in shares)           3,320,235                      
Issuance of common stock in acquisition 9,472                   9,472            
Vesting of early exercised stock options and common stock issued in private placement 30                   30            
Other comprehensive income (loss) (452)                               (452)
Common stock, ending balance (in shares) at Jun. 30, 2024           713,879,586                      
Ending balance at Jun. 30, 2024 894,584         $ 71         2,362,128         (1,465,582) (2,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (143,878)                             (143,878)  
Stock-based compensation 27,391                   27,391            
Issuance of common stock upon exercise of stock options (in shares)           1,015,276                      
Issuance of common stock upon exercise of stock options 207                   207            
Issuance of common stock upon the release of restricted stock units (in shares)           2,199,221                      
Vesting of early exercised stock options and common stock issued in private placement 25                   25            
Other comprehensive income (loss) 2,710                               2,710
Common stock, ending balance (in shares) at Sep. 30, 2024           717,094,083                      
Ending balance at Sep. 30, 2024 $ 781,039         $ 71         2,389,751         (1,609,460) 677
Common stock, beginning balance (in shares) at Dec. 31, 2024 784,176,364         784,176,364                      
Beginning balance at Dec. 31, 2024 $ 912,363         $ 78         2,768,605         (1,855,737) (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (82,406)                             (82,406)  
Stock-based compensation 27,019                   27,019            
Issuance of common stock upon exercise of stock options (in shares)           807,475                      
Issuance of common stock upon exercise of stock options 547                   547            
Issuance of common stock upon the release of restricted stock units (in shares)           4,063,821                      
Issuance of common stock (in shares)                 246,167                
Issuance of common stock       $ 1,994         $ 1         $ 1,993      
Vesting of early exercised stock options and common stock issued in private placement 13                   13            
Other comprehensive income (loss) (89)                               (89)
Common stock, ending balance (in shares) at Mar. 31, 2025           789,293,827                      
Ending balance at Mar. 31, 2025 $ 859,441         $ 79         2,798,177         (1,938,143) (672)
Common stock, beginning balance (in shares) at Dec. 31, 2024 784,176,364         784,176,364                      
Beginning balance at Dec. 31, 2024 $ 912,363         $ 78         2,768,605         (1,855,737) (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss $ (808,306)                                
Common stock, ending balance (in shares) at Sep. 30, 2025 874,277,241         874,277,241                      
Ending balance at Sep. 30, 2025 $ 896,452         $ 87         3,559,790         (2,664,043) 618
Common stock, beginning balance (in shares) at Mar. 31, 2025           789,293,827                      
Beginning balance at Mar. 31, 2025 859,441         $ 79         2,798,177         (1,938,143) (672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (324,674)                             (324,674)  
Stock-based compensation 26,558                   26,558            
Issuance of common stock upon exercise of stock options (in shares)           886,924                      
Issuance of common stock upon exercise of stock options 421                   421            
Issuance of common stock upon the release of restricted stock units (in shares)           3,736,901                      
Issuance of common stock (in shares)                 5,853,452 49,701,790              
Issuance of common stock       40,968 $ 290,163       $ 1 $ 5       40,967 $ 290,158    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)           1,148,609                      
Issuance of common stock under the Employee Stock Purchase Plan 5,022                   5,022            
Vesting of early exercised stock options and common stock issued in private placement 275                   275            
Other comprehensive income (loss) 118                               118
Common stock, ending balance (in shares) at Jun. 30, 2025           850,621,503                      
Ending balance at Jun. 30, 2025 898,292         $ 85         3,161,578         (2,262,817) (554)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net loss (401,226)                             (401,226)  
Stock-based compensation 30,232                   30,232            
Issuance of common stock upon exercise of stock options (in shares)           1,209,289                      
Issuance of common stock upon exercise of stock options 1,252                   1,252            
Issuance of common stock upon the release of restricted stock units (in shares)           3,051,514                      
Issuance of common stock (in shares)                 7,059,395                
Issuance of common stock       $ 100,910         $ 1         $ 100,909      
Issuance of common stock upon exercise of warrants (in shares)             4,128,197 2,881,758                  
Issuance of common stock upon exercise of warrants   $ 70,468 $ 58,700                 $ 70,468 $ 58,700        
Issuance of common stock in acquisition (in shares)           5,325,585                      
Issuance of common stock in acquisition 75,943         $ 1         75,942            
Vesting of earnout shares 60,709                   60,709            
Other comprehensive income (loss) $ 1,172                               1,172
Common stock, ending balance (in shares) at Sep. 30, 2025 874,277,241         874,277,241                      
Ending balance at Sep. 30, 2025 $ 896,452         $ 87         $ 3,559,790         $ (2,664,043) $ 618